700 related articles for article (PubMed ID: 17647238)
1. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation.
Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS
J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238
[TBL] [Abstract][Full Text] [Related]
2. Influence of electron-beam radiation on the hydrolytic degradation behaviour of poly(lactide-co-glycolide) (PLGA).
Loo SC; Ooi CP; Boey YC
Biomaterials; 2005 Jun; 26(18):3809-17. PubMed ID: 15626429
[TBL] [Abstract][Full Text] [Related]
3. Hydrolytic degradation characteristics of irradiated multi-layered PLGA films.
Joachim Loo SC; Jason Tan WL; Khoa SM; Chia NK; Venkatraman S; Boey F
Int J Pharm; 2008 Aug; 360(1-2):228-30. PubMed ID: 18514448
[TBL] [Abstract][Full Text] [Related]
4. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour.
Unger F; Wittmar M; Morell F; Kissel T
Biomaterials; 2008 May; 29(13):2007-14. PubMed ID: 18262641
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
[TBL] [Abstract][Full Text] [Related]
7. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
8. Effect of ganciclovir on the hydrolytic degradation of poly(lactide-co-glycolide) microspheres.
Chen X; Ooi CP; Lim TH
J Biomater Appl; 2006 Jan; 20(3):287-302. PubMed ID: 16364967
[TBL] [Abstract][Full Text] [Related]
9. Fabrication and characterization of permeable degradable poly(DL-lactide-co-glycolide) (PLGA) hollow fiber phase inversion membranes for use as nerve tract guidance channels.
Wen X; Tresco PA
Biomaterials; 2006 Jul; 27(20):3800-9. PubMed ID: 16564567
[TBL] [Abstract][Full Text] [Related]
10. Production of microspheres with surface amino groups from blends of Poly(Lactide-co-glycolide) and Poly(epsilon-CBZ-L-lysine) and use for encapsulation.
Zheng J; Hornsby PJ
Biotechnol Prog; 1999; 15(4):763-7. PubMed ID: 10441368
[TBL] [Abstract][Full Text] [Related]
11. In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering.
Wu L; Ding J
Biomaterials; 2004 Dec; 25(27):5821-30. PubMed ID: 15172494
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment.
Wang Y; Challa P; Epstein DL; Yuan F
Biomaterials; 2004 Aug; 25(18):4279-85. PubMed ID: 15046918
[TBL] [Abstract][Full Text] [Related]
14. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
15. Internal morphology of poly(D,L-lactide-co-glycolide) BCNU-loaded microspheres. Influence on drug stability.
Painbeni T; Venier-Julienne MC; Benoit JP
Eur J Pharm Biopharm; 1998 Jan; 45(1):31-9. PubMed ID: 9689533
[TBL] [Abstract][Full Text] [Related]
16. Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres.
Ito F; Makino K
Colloids Surf B Biointerfaces; 2004 Nov; 39(1-2):17-21. PubMed ID: 15542335
[TBL] [Abstract][Full Text] [Related]
17. In vitro degradation of polyanhydride/polyester core-shell double-wall microspheres.
Pollauf EJ; Berkland C; Kim KK; Pack DW
Int J Pharm; 2005 Sep; 301(1-2):294-303. PubMed ID: 16051452
[TBL] [Abstract][Full Text] [Related]
18. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier.
Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G
Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109
[TBL] [Abstract][Full Text] [Related]
19. Characterization of surface property of poly(lactide-co-glycolide) after oxygen plasma treatment.
Wan Y; Qu X; Lu J; Zhu C; Wan L; Yang J; Bei J; Wang S
Biomaterials; 2004 Aug; 25(19):4777-83. PubMed ID: 15120524
[TBL] [Abstract][Full Text] [Related]
20. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
McCarron PA; Marouf WM; Donnelly RF; Scott C
J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
